Treatment of colorectal liver metastases: A current view;Soudobý pohled na léčbu jaterních metastáz kolorektálního karcinomu

Klinicka Onkologie

Volumn 23, Issue 2, 2010, Pages 73-77

  Oliverius, Martin ^a   Safanda M ^b   Petruzelka L ^c  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adjuvant chemotherapy; Liver metastases; Liver resection; Perioperative chemotherapy; Portal vein embolisation; Radiofrequency ablation

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; VASCULOTROPIN;

BIOLOGICAL THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COLORECTAL CANCER; DISEASE FREE INTERVAL; FATTY LIVER; LIVER METASTASIS; LIVER RESECTION; LIVER TOXICITY; MORBIDITY; MORTALITY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRACTICE GUIDELINE; RADIOFREQUENCY ABLATION; REVIEW; RISK REDUCTION;

EID: 77951991510     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Nordlinger B, Van Cutsem E, Rougier P et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group Eur J Cancer 2007; 43(14). 2037-2045. (Pubitemid 47380368)
2. Adson MA. Resection of liver metastases - when is it worthwhile? World J Surg 1987; 11(4): 511-520.
3. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990; 77(11): 1241-1246
4. Kokudo N, Miki Y, Sugai S et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 2002; 137(7): 833-840. (Pubitemid 34743176)
5. de Haas RJ, Wicherts DA, Flores E et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 2008; 248(4): 626-637.
6. Fong Y, Fortner J, Sun RL et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1 001 consecutive cases. Ann Surg 1999; 230(3): 309-321. (Pubitemid 30191861)
7. Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1 568 patients. Association Française de Chirurgie. Cancer 1996; 77(7): 1254-1262.
8. Treska V, Topolcan O, Stanislav K et al. Preoperative tumor markers as prognostic factors of colorectal liver metastases. Hepatogastroenterology 2009, 56(90):317-320.
9. Lambert LA, Colacchio TA, Barth RJ Jr. Interval hepatic resection of colorectal liver metastases improves patient selection. Arch Surg 2000; 135(4): 473-480. (Pubitemid 30198520)
10. Adam R. Colorectal carcinoma with synchronous liver metastases. Br J Surg 2007; 94(2): 129-131. (Pubitemid 46340389)
11. Weber JC, Bachellier P, Oussoultzoglou E et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003; 90(8): 956-962. (Pubitemid 37026324)
12. Benoist S, Pautrat K, Mitry E et al. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005; 92(9): 1155-1160. (Pubitemid 41284882)
13. Ablorsu E, Kothaj P. Súčasné postavenie chirurgie v liečbe pečeňových metastáz kolorektálneho karcinómu. Klin Onkol 2006; 19(2): 121-123. (Pubitemid 44767364)
14. Mentha G, Majno PE, Andres A et al. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of colorectal primary. Br J Surg 2006; 93(7): 872-878. (Pubitemid 44035261)
15. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005,23(9): 2038-2048. (Pubitemid 46211384)
16. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23(9): 2038-2048. (Pubitemid 46211384)
17. Treska V, Skalický T, Sutnar A et al. Surgical management of the colorectal carcinoma liver metastases. Rozhl Chir 2009; 88(2): 69-74.
18. Alberts SR. Updated options for liver-limited metastatic colorectal cancer. Clin Colorectal Cancer 2008, 7 (Suppl 2):S58-S62.
19. Nordlinger B, Sorbye H, Collette L et al. Final results of the EORTC lntergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. Proc Am Soc Clin Oncol 2007; 25. 962s.
20. Gruenberger B, Scheithauer W, Punzengruber R et al. Importance of response to neoadjuvant chemotherapy in potentially curable colorectal liver metastases. BMC Cancer 2008; 8: 120.
21. Gruenberger B, Tamandl D, Schueller J et al. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 2008; 26(11): 1830-1835.
22. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5(6): 649-655.
23. Adam R, Aloia T Lévi F et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 2007; 25(29): 4593-4602. (Pubitemid 350035318)
24. Rubbia-Brandt L, Audard V, Sartoretti P et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15(3): 460-466. (Pubitemid 38444550)
25. Aloia T, Sebagh M, Plasse M et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24(31): 4983-4990. (Pubitemid 46631400)
26. Younes RN, Rogatko A Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases Ann Surg 1991;214(2) 107-113.
27. Vauthey JN, Pawlik TM, Ribero D et al. Chemotherapy regiment predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24(13): 2065-2072
28. Nordlinger B, Benoist S. Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol 2006; 24(311:4954-4955. (Pubitemid 46631395)
29. Benoist S, Brouquet A, Penna C et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006; 24(24): 3939-3945. (Pubitemid 46630742)
30. Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240(4): 644-658. (Pubitemid 39281287)